INSM Stock: $60 Price Target From Cantor Fitzgerald

By Amit Chowdhry ● Oct 11, 2021
  • The shares of Insmed Incorporated (NASDAQ: INSM) have received a $60 price target from Cantor Fitzgerald. These are the details.

The shares of Insmed Incorporated (NASDAQ: INSM) have received a $60 price target from Cantor Fitzgerald. And Cantor Fitzgerald analyst Jennifer Kim initiated coverage of Insmed with an “Overweight” rating.

Kim believes that Insmed is approaching an inflection point as it executes on becoming a self-sustaining and leading rare disease company. And Kim pointed out that Insmed is well-capitalized to deliver on its pipeline and feels that upwards earnings estimate revisions – driven by product and pipeline advancements – should move the stock higher.

Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.